North America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Dosage, Disease, and Technology

North America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Dosage, Disease, and Technology

  • July 2021 •
  • 110 pages •
  • Report ID: 6134406 •
  • Format: PDF
The North America poultry vaccines market is expected to grow from US$ 901.74 million in 2021 to US$ 1,449.99 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028.

Rising demand for healthy poultry food is expected to escalate the market growth.The growing demand for healthy chicken food in the market promotes governments to create suitable laws and regulations for the safety of animals in the poultry business.

For example, infections with Campylobacter and Salmonella are the two most common foodborne illnesses caused by eating chicken meat.Human instances of influenza h5n1 infection has been linked to the consumption of raw or undercooked chicken or chicken products (hPai).

Thus, the vaccine has also been well-received, as the expense of vaccinating the entire flock is covered by the sale price of a single chicken.The funds are utilized to support a variety of family requirements, including paying their children’s education and purchasing critical agricultural products for their crops.

Based on the demands, there has been a rise in the production of poultry products in region; however, this overall increase is not occurring in the countries like Mexico, rather declining. With the increased production of poultry products, there will also be increased demand for vaccines to keep poultry safe. Because of the growing need for high-quality meat and eggs, the demand for chicken meat has grown throughout time. Poultry birds are susceptible to a variety of fowl illnesses, which cause significant economic losses to the poultry business. Even though chickens are susceptible to bacterial, viral, parasitic, and fungal infections, the outbreaks due to viral infection such as Newcastle disease (ND), Avian Influenza (AI), Infectious Bursal Disease (IBD), and Infectious Bronchitis (IB) cause a great need of vaccines to maintain safety, thereby driving the North America poultry vaccines market.

In case of COVID-19, North America is highly affected specially the US.The incidence of corona virus or COVID 19 has not yet been registered the animals.

Also, there is no evidence that poultry birds are the prime source of the spreading epidemic in humans.However, various studies have been conducted to check the spread of disease from animals to humans.

In many cases, zoonotic diseases were found in humans due to interaction with animals.Therefore, government bodies are taking more precautions and safety measures to prevent the spread of corona virus in the animals.

The measures are widely carried out for companion animals as they frequently come in contact with their owners. Also, it is essential to report the cases to a veterinary authority. For instance, in the region, to report the cases of detection of COVID-19 is done to OIE through WAHIS, in accordance with the OIE Terrestrial Animal Health Code as an emerging disease. The COVID-19 pandemic and the associated lockdown for a long period have created a significant adverse impact on different sectors, including that of the agriculture and other allied sub-sectors in India and several other countries. The OIE is actively working by aiding research for their on-going research and other implications of COVID-19 for animal health and poultry public health. The assistance is also providing risk assessment, risk management, and risk communication.

The liquid vaccines segment led the North America poultry vaccines market based on dosage in 2020.Vaccine manufacture and composition is complex and tightly regulated to maximize potency and safety.

The safety of the individual components, and of the vaccine itself, in the amounts administered, A diluent is a liquid used to dilute a vaccine to the proper concentration immediately prior to administration.This is usually sterile water.

Vaccines are administered in liquid form, either by injection, by oral, or by intranasal routes. Advantages of liquid vaccine such as safer, good efficiency, easy to use, less costly etc. are expected to increase its demand, thereby driving the North America poultry vaccines market in coming years.

The overall North America poultry vaccines market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the North America poultry vaccines market.

The process also serves the purpose of obtaining overview and forecast for the North America poultry vaccines market with respects to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.

The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the North America poultry vaccines market. Boehringer Ingelheim International GmbH; CEVA; Merck & Co., Inc.; PHIBRO POULTRY VACCINES CORPORATION; Virbac; and Zoetis Inc. are among a few players operating in the North America poultry vaccines market.

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.